Prospective, Open-Label, Multi-Center, Phase III Clinica

Project: Research project

Project Details

Description

Prospective, Open-Label, Multi-Center, Phase III Clinical Study To Investigate the Efficacy And Safety of Human Factor VWF/VIII Concentrate (Wilate)In Subjects With Inherited Type 3 Von Willebrand Disease (VWD) Who Undergo Major Surgical Procedures
StatusFinished
Effective start/end date3/14/123/13/17

Funding

  • OCTAPHARMA USA, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.